These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 28923878)

  • 61. Phenotypic and genotypic evaluation of 18 Nocardia isolates from human clinical samples in Mexico.
    Sánchez-Herrera K; Sandoval H; Couble A; Mouniee D; Ramírez-Durán N; Uzcategui de Morillo M; Serrano JA; Bergeron E; Boiron P; Rodríguez-Nava V
    J Mycol Med; 2012 Mar; 22(1):1-7. PubMed ID: 23177807
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Nocardiosis in 132 patients with cancer: microbiological and clinical analyses.
    Wang HL; Seo YH; LaSala PR; Tarrand JJ; Han XY
    Am J Clin Pathol; 2014 Oct; 142(4):513-23. PubMed ID: 25239419
    [TBL] [Abstract][Full Text] [Related]  

  • 63. In vitro activity of tedizolid against gram-positive bacteria in patients with skin and skin structure infections and hospital-acquired pneumonia: a Korean multicenter study.
    Lee Y; Hong SK; Choi S; Im W; Yong D; Lee K
    Ann Lab Med; 2015 Sep; 35(5):523-30. PubMed ID: 26206690
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Tedizolid in vitro activity against Gram-positive clinical isolates causing bone and joint infections in hospitals in the USA and Europe (2014-17).
    Carvalhaes CG; Sader HS; Flamm RK; Mendes RE
    J Antimicrob Chemother; 2019 Jul; 74(7):1928-1933. PubMed ID: 30932152
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Nocardia species distribution and antimicrobial susceptibility within Australia.
    O'Brien A; Hart J; Higgins A; Arthur I; Lee GH; Leung M; Kennedy K; Bradbury S; Foster S; Warren S; Korman TM; Abbott IJ; Heney C; Bletchley C; Warner M; Wells N; Wilson D; Varadhan H; Stevens R; Lahra M; Newton P; Maley M; van Hal S; Ingram PR
    Intern Med J; 2024 Apr; 54(4):613-619. PubMed ID: 37929813
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Early experience with tedizolid: clinical efficacy, pharmacodynamics, and resistance.
    Rybak JM; Marx K; Martin CA
    Pharmacotherapy; 2014 Nov; 34(11):1198-208. PubMed ID: 25266820
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Tedizolid: The First Once-Daily Oxazolidinone Class Antibiotic.
    Burdette SD; Trotman R
    Clin Infect Dis; 2015 Oct; 61(8):1315-21. PubMed ID: 26105167
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Clinical significance, antimicrobial susceptibility and molecular identification of Nocardia species isolated from children with cystic fibrosis.
    Betrán A; Villuendas MC; Rezusta A; Pereira J; Revillo MJ; Rodríguez-Nava V
    Braz J Microbiol; 2016; 47(3):531-5. PubMed ID: 27155949
    [TBL] [Abstract][Full Text] [Related]  

  • 69. In-vitro activity of flomoxef, a new oxacephem group antibiotic, against Nocardia in comparison with other cephalosporins.
    Yazawa K; Mikami Y; Uno J; Otozai K; Arai T
    J Antimicrob Chemother; 1989 Dec; 24(6):921-5. PubMed ID: 2621177
    [TBL] [Abstract][Full Text] [Related]  

  • 70. In vitro, in vivo, and clinical studies of tedizolid to assess the potential for peripheral or central monoamine oxidase interactions.
    Flanagan S; Bartizal K; Minassian SL; Fang E; Prokocimer P
    Antimicrob Agents Chemother; 2013 Jul; 57(7):3060-6. PubMed ID: 23612197
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Microbiological and clinical features of nine cases with nocardial infections].
    Maki Y; Uchida Y; Monji N; Mochimaru T; Morokuma Y; Karashima T; Kiyosuke M; Fujise M; Eto F; Miyake N; Shimono N; Kayamori Y; Kang D
    Rinsho Byori; 2011 Mar; 59(3):213-8. PubMed ID: 21560401
    [TBL] [Abstract][Full Text] [Related]  

  • 72. In vitro activity of tedizolid against staphylococci isolated from prosthetic joint infections.
    Schmidt-Malan SM; Greenwood Quaintance KE; Karau MJ; Patel R
    Diagn Microbiol Infect Dis; 2016 May; 85(1):77-9. PubMed ID: 26906190
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Antimicrobial-resistant nocardia isolates, United States, 1995-2004.
    Uhde KB; Pathak S; McCullum I; Jannat-Khah DP; Shadomy SV; Dykewicz CA; Clark TA; Smith TL; Brown JM
    Clin Infect Dis; 2010 Dec; 51(12):1445-8. PubMed ID: 21058914
    [TBL] [Abstract][Full Text] [Related]  

  • 74. In vitro susceptibility testing of imipenem-relebactam and tedizolid against 102 Mycobacterium abscessus isolates.
    Burke A; Carter R; Tolson C; Congdon J; Duplancic C; Bursle E; Bell SC; Roberts JA; Thomson R
    Int J Antimicrob Agents; 2023 Oct; 62(4):106938. PubMed ID: 37517624
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Speciation and susceptibility of Nocardia isolated from ocular infections.
    Reddy AK; Garg P; Kaur I
    Clin Microbiol Infect; 2010 Aug; 16(8):1168-71. PubMed ID: 19832708
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Efficacy of DA-7218, a new oxazolidinone prodrug, in the treatment of experimental actinomycetoma produced by Nocardia brasiliensis.
    Espinoza-González NA; Welsh O; de Torres NW; Cavazos-Rocha N; Ocampo-Candiani J; Said-Fernandez S; Lozano-Garza G; Choi SH; Vera-Cabrera L
    Molecules; 2008 Jan; 13(1):31-40. PubMed ID: 18259127
    [TBL] [Abstract][Full Text] [Related]  

  • 77. In Vitro Comparison of Ertapenem, Meropenem, and Imipenem against Isolates of Rapidly Growing Mycobacteria and Nocardia by Use of Broth Microdilution and Etest.
    Brown-Elliott BA; Killingley J; Vasireddy S; Bridge L; Wallace RJ
    J Clin Microbiol; 2016 Jun; 54(6):1586-1592. PubMed ID: 27053677
    [TBL] [Abstract][Full Text] [Related]  

  • 78. In vitro activity of tedizolid against the Mycobacterium abscessus complex.
    Compain F; Soroka D; Heym B; Gaillard JL; Herrmann JL; Dorchène D; Arthur M; Dubée V
    Diagn Microbiol Infect Dis; 2018 Mar; 90(3):186-189. PubMed ID: 29217419
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Clinical manifestations and antimicrobial susceptibility of Nocardia species at a tertiary hospital in Taiwan, 2011-2020.
    Lao CK; Tseng MC; Chiu CH; Chen NY; Chen CH; Chung WH; Liu TP; Lu JJ; Lai HC; Yang LY; Lee CH; Wu TS
    J Formos Med Assoc; 2022 Oct; 121(10):2109-2122. PubMed ID: 35811270
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Identification of medically relevant Nocardia species with an abbreviated battery of tests.
    Kiska DL; Hicks K; Pettit DJ
    J Clin Microbiol; 2002 Apr; 40(4):1346-51. PubMed ID: 11923355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.